Key result
Wearable and implanted devices tracking heart rate variability gain traction for early AF screening.
Why the study?
AF is often initially asymptomatic but contributes to morbidity and mortality, driving interest in new screening and detection approaches across healthy subjects and at-risk patients.
Answers are grounded in this paper and cite their sources.
May support wearable AF screening for earlier detection; hypothesis-generating and requires validation before practice change.
Atrial fibrillation (AF) in adults is the most common sustained arrhythmia and is, in majority of patients, initially asymptomatic. 1 However, AF and its complications contribute significantly and negatively to patients' quality of life as well as cardiovascular morbidity and mortality. Thus, early diagnosis and introduction of appropriate treatment are of great importance to help prevent adverse clinical outcomes. There is an increasing interest regarding new approaches in the screening and detection of cardiovascular conditions, including AF, both in ostensibly healthy subjects and in patients with various risk factors and/or diseases.
No takes yet. Share an insight, caveat, or question.
Matusik et al. (2022) conducted a review in Atrial fibrillation. Wearable and implanted devices was evaluated. Wearable and implanted devices measuring heart rate variability and patterns are of increasing interest for the screening and early detection of atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: